Novel Pyrazolopyrimidopyridazinones with Potent and Selective Phosphodiesterase 5 (PDE5) Inhibitory Activity as Potential Agents for Treatment of Erectile Dysfunction-Reference-Cited by-同舟云学术

Novel Pyrazolopyrimidopyridazinones with Potent and Selective Phosphodiesterase 5 (PDE5) Inhibitory Activity as Potential Agents for Treatment of Erectile Dysfunction

Published:2006-08-01 Issue:17 Volume:49 Page:5363-5371
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Giovannoni Maria Paola¹,Vergelli Claudia¹,Biancalani Claudio¹,Cesari Nicoletta¹,Graziano Alessia¹,Biagini Pierfrancesco¹,Gracia Jordi¹,Gavaldà Amadeu¹,Dal Piaz Vittorio¹

Affiliation:

1. Dipartimento di Scienze Farmaceutiche, Università di Firenze, Via Ugo Schiff 6, Sesto Fiorentino, 50019 Firenze, Italy, and Almirall Prodesfarma Research Center, Cardener 68-74, 08024 Barcelona, Spain

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm060265%2B

Reference44 articles.

1. THE EPIDEMIOLOGY OF ERECTILE DYSFUNCTION

2. Impotence and Its Medical and Psychosocial Correlates: Results of the Massachusetts Male Aging Study

3. INCIDENCE OF ERECTILE DYSFUNCTION IN MEN 40 TO 69 YEARS OLD: LONGITUDINAL RESULTS FROM THE MASSACHUSETTS MALE AGING STUDY

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Lateral Metalation of Isoxazolo[3,4-d]pyridazinones towards Hit-to-Lead Development of Selective Positive Modulators of Metabotropic Glutamate Receptors;Molecules;2023-09-25

2. New Spiro[cycloalkane-pyridazinone] Derivatives with Favorable Fsp3 Character;Chemistry;2020-10-06

3. Synthesis of Spiro[cycloalkane-pyridazinones] with High Fsp3 Character;Letters in Drug Design & Discovery;2020-06-29

4. Isoxazolo[3,4-d]pyridazinones positively modulate the metabotropic glutamate subtypes 2 and 4;Bioorganic & Medicinal Chemistry;2018-09

5. Synthesis and biological evaluation of pyridazinone derivatives as potential anti-inflammatory agents;European Journal of Medicinal Chemistry;2018-02